Solu-cortef and Interstitial lung disease - a phase IV clinical study of FDA data

Summary:

Interstitial lung disease is reported as a side effect among people who take Solu-cortef (hydrocortisone sodium succinate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Interstitial lung disease when taking Solu-cortef. It is created by eHealthMe based on reports of 7,966 people who have side effects when taking Solu-cortef from the FDA, and is updated regularly.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,500 drugs and 1,841 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

7,966 people reported to have side effects when taking Solu-cortef.
Among them, 66 people (0.83%) have Interstitial lung disease.

Could Solu-cortef cause Interstitial lung disease?

Among these 66 people:

How long have people been on Solu-cortef when they have Interstitial lung disease? *

What is the gender of people who have Interstitial lung disease when taking Solu-cortef? *

female: 32.73 %
male: 67.27 %

What is the age of people who have Interstitial lung disease when taking Solu-cortef? *

What are other drugs people take besides Solu-cortef? *

What are other side effects people have besides Interstitial lung disease? *

Fever: 15 people, 22.73%
Pneumonia: 14 people, 21.21%
Thrombocytopenia (decrease of platelets in blood): 13 people, 19.70%
White Blood Cell Count Decreased: 12 people, 18.18%
Hepatic Function Abnormal: 10 people, 15.15%
Cytomegalovirus Infection: 9 people, 13.64%
Constipation: 8 people, 12.12%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 8 people, 12.12%
Dyspnea (difficult or laboured breathing): 8 people, 12.12%
Hypotension (abnormally low blood pressure): 7 people, 10.61%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 22.73%
Fever: 7 people, 10.61%
Insomnia (sleeplessness): 6 people, 9.09%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 6 people, 9.09%
Infection: 6 people, 9.09%
Constipation: 5 people, 7.58%
Pneumonia Mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection): 4 people, 6.06%
Rashes (redness): 4 people, 6.06%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.06%
Cytomegalovirus Infection: 3 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and have Interstitial lung disease?

- Check whether Interstitial lung disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Solu-cortef:

Solu-cortef (7,983 reports)

Interstitial lung disease treatments and more:

Interstitial lung disease (69,102 reports)

How severe was Interstitial lung disease and when was it recovered:

Interstitial lung disease in Solu-cortef

Expand to all the drugs that have ingredients of hydrocortisone sodium succinate:

Interstitial lung disease and drugs with ingredients of hydrocortisone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate (the active ingredients of Solu-cortef) and Solu-cortef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.